DISEÑO IN SILICO DE IMIDAZOLES FUNCIONALIZADOS CON AMINOÁCIDOS COMO INHIBIDORES DE LAS PROTEÍNAS NS3 Y NS5 DEL VIRUS DEL DENGUE

Autores

  • Yonatan Mederos-Núñez Departamento de Química, Facultad de Ciencias Naturales y Exactas. Universidad de Oriente. Santiago de Cuba, Cuba
  • Yoan A. Pérez-Garmury UEB Laboratorio, Refinería Hermanos Díaz, Cupet, Santiago de Cuba, Cuba
  • Armando Ferrer-Serrano Departamento de Química Orgânica. Instituto de Química. Universidade Federal da Bahia. Brasil
  • Julio A. Rojas-Vargas Departamento de Química, Facultad de Ciencias Naturales y Exactas. Universidad de Oriente. Santiago de Cuba, Cuba
  • América García-López Departamento de Química, Facultad de Ciencias Naturales y Exactas. Universidad de Oriente. Santiago de Cuba, Cuba

Palavras-chave:

diseño de fármacos; acoplamiento molecular; ADME+T; DFT; virus del dengue; imidazoles funcionalizados con aminoácidos.

Resumo

Se diseñaron 252 imidazoles funcionalizados con aminoácidos para evaluar sus
posibilidades como inhibidores, mediante técnicas computacionales. Un análisis de los
perfiles ADME+T indica, que los compuestos derivados de los aminoácidos polares Ser y
Thr, son los más favorables como candidatos a fármacos. De estos compuestos, cuatro (SerA22, Thr-A22, Ser-A35 y Thr-A35) resaltan como candidatos a inhibidores de las proteínas
NS3 en su dominio helicasa y NS5 en su dominio metiltransferasa. Para los dominios NS2BNS3Pro y NS5RdRp los resultados no son alentadores. Un análisis de las densidades
electrónicas de estos cuatro compuestos mediante DFT, arrojó la similitud con inhibidores
de referencia en cuanto a orbitales de frontera, reactividad y superficies de potencial
electrostático, lo cual explica la fortaleza de la unión de estos compuestos con las proteínas
virales.

Referências

TAYAL, A.; KABRA, S. K.; LODHA, R.

"Management of Dengue: An Updated Review".

Indian Journal of Pediatrics, February 2023, 90(2),

-177. https://doi.org/10.1007/s12098-022-04394-8

ROSS, T. M. "Dengue virus". Clinics in laboratory

medicine, 2010, 30(1), 149-160. ISSN: 0272-2712.

https://doi.org/10.1016/j.cll.2009.10.007

GUZMÁN, M. G. et al. "Vigilancia de laboratorio

de dengue y otros arbovirus en Cuba, 1970-2017".

Revista Cubana de Medicina Tropical, 2019, 71(1), 1-

ISSN: 1561-3054.

http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=

S0375-07602019000100008

ANTÔNIO, G. D. et al. "A Febre Oropouche como

diagnóstico diferencial entre demais arboviroses".

Brazilian Journal of Health Review, 2024, 7(3),

e70931-e70931. ISSN: 2595-6825.

https://doi.org/10.34119/bjhrv7n3-506

BELTRÁN-SILVA, S. L.; CHACÓNHERNÁNDEZ, S.; MORENO-PALACIOS, E.;

PEREYRA-MOLINA, J. "Clinical and differential

diagnosis: Dengue, chikungunya and Zika". Revista

Médica del Hospital General de México, 2018, 81(3),

-153. ISSN: 0185-1063.

https://doi.org/10.1016/j.hgmx.2016.09.011

CHICO ALDAMA, P. "Ciclo de vida del Aedes

aegypti y manifestaciones clínicas del dengue". Acta

Pediátrica de México, 2019, 22(2), 114-117. ISSN:

-2391.

http://repositorio.pediatria.gob.mx:8180/handle/20.50

12103/1532

TORRES‑FLORES, J. M.; REYES‑SANDOVAL,

A.; SALAZAR, M. I. "Dengue Vaccines: An Update".

BioDrugs, 2022, 36, 325-336.

https://doi.org/10.1007/s40259-022-00531-z

WIWANITKIT, V. "Dengue fever: diagnosis and

treatment". Expert review of anti-infective therapy,

, 8(7), 841-845. ISSN: 1478-7210.

https://doi.org/10.1586/eri.10.53

ASSIR, M. Z. K. et al. "Effectiveness of platelet

transfusion in dengue fever: a randomized controlled

trial". Transfusion Medicine and Hemotherapy, 2013,

(5), 362-368. ISSN: 1660-3796.

https://doi.org/10.1159/000354837

SULIMAN, M. I.; QAYUM, I.; SAEED, F.

"Randomized clinical trial of human interleukin-11 in

dengue fever-associated thrombocytopenia". J. Coll

Physician Surg Pak, 2014, 24(3), 164-168, ISSN:

-386X.

https://www.jcpsp.pk/archive/2014/Mar2014/05.pdf

CHAN, C. Y.; OOI, E. E. "Dengue: an update on

treatment options". Future microbiology, 2015,

(12), 2017-2031. ISSN: 1746-0913.

https://doi.org/10.2217/fmb.15.105

HARAPAN, H.; MICHIE, A.; SASMONO, R. T.;

IMRIE, A. "Dengue: a minireview". Viruses, 2020,

(8), 829. ISSN: 1999-4915.

https://doi.org/10.3390/v12080829

SOBHIA, M. E. et al. "A Multi-Perspective Review

on Dengue Research". Current Drug Targets, 2019,

(15), 1550-1562. ISSN: 1389-4501.

https://doi.org/10.2174/1389450120666190724145937

DONG, H. et al. "Flavivirus RNA methylation".

Journal of General Virology, 2014, 95(4), 763-778. ISSN: 0022-1317.

https://doi.org/10.1099/vir.0.062208-0

DONG, H. et al. "Flavivirus RNA methylation".

Journal of General Virology, 2014, 95(4), 763-778.

ISSN: 0022-1317.

https://doi.org/10.1099/vir.0.062208-0

BOLLATI, M. et al. "Structure and functionality

in flavivirus NS-proteins: perspectives for drug

design". Antiviral research, 2010, 87(2), 125-148.

ISSN: 0166-3542.

https://doi.org/10.1016/j.antiviral.2009.11.009

VALLE, R. P.; FALGOUT, B. "Mutagenesis of

the NS3 protease of dengue virus type 2". Journal of

virology, 1998, 72(1), 624-632. ISSN: 1098-5514.

https://doi.org/10.1128/jvi.72.1.624-632.1998

ZUO, Z. et al. "Mechanism of NS2B-mediated

activation of NS3pro in dengue virus: molecular

dynamics simulations and bioassays". Journal of

virology, 2009, 83(2), 1060-1070. ISSN: 0022-538X.

https://doi.org/10.1128/jvi.01325-08

SAMPATH, A; PADMANABHAN, R.

"Molecular targets for flavivirus drug discovery".

Antiviral research, 2009, 81(1), 6-15. ISSN: 0166-

https://doi.org/10.1016/j.antiviral.2008.08.004

OLIVEIRA, A. S. D. et al. "NS3 and NS5

proteins: important targets for anti-dengue drug

design". Journal of the Brazilian Chemical Society,

, 25, 1759-1769. ISSN: 0103-5053.

https://doi.org/10.5935/0103-5053.20140057

TROOST, B.; SMIT, J. M. "Recent advances in

antiviral drug development towards dengue virus".

Current opinion in virology, 2020, 43, 9-21. ISSN:

-6257.

https://doi.org/10.1016/j.coviro.2020.07.009

N POWERS, C.; SETZER, W. N. "An insilico investigation of phytochemicals as antiviral

agents against dengue fever". Combinatorial

chemistry & high throughput screening, 2016,

(7), 516-536. ISSN: 1386-2073.

https://doi.org/10.2174/13862073196661605061

CHEW, M. F.; POH, K. S.; POH, C. L. "Peptides

as therapeutic agents for dengue virus". International

journal of medical sciences, 2017, 14(13), 1342.

https://doi.org/10.7150/ijms.21875

DELGADO-MALDONADO, T. et al. "Recent

advances in the development of methyltransferase

(MTase) inhibitors against (re) emerging arboviruses

diseases dengue and Zika". European Journal of

Medicinal Chemistry, 2023, 252, 115290. ISSN:

-5234.

https://doi.org/10.1016/j.ejmech.2023.115290

DOS SANTOS NASCIMENTO, I. J. et al.

"Advances in computational methods to discover new

NS2B-NS3 inhibitors useful against dengue and Zika

viruses". Current Topics in Medicinal Chemistry,

, 22(29), 2435-2462. ISSN: 1568-0266.

https://doi.org/10.2174/1568026623666221122

OBI, J. O.; GUTIÉRREZ-BARBOSA, H.; CHUA,

J. V.; DEREDGE, D. J. "Current trends and

limitations in dengue antiviral research". Tropical

Medicine and Infectious Disease, 2021, 6(4), 180.

ISSN: 2414-6366.

https://doi.org/10.3390/tropicalmed6040180

VARGAS, J. A. R. et al. "In vitro evaluation of

arylsubstituted imidazoles derivatives as antiprotozoal

agents and docking studies on sterol 14α-demethylase

(CYP51) from Trypanosoma cruzi, Leishmania

infantum, and Trypanosoma brucei". Parasitology

research, 2019, 118(5), 1533-1548. ISSN: 1432-1955.

https://doi.org/10.1007/s00436-019-06206-z

FU, L. et al. "ADMETlab 3.0: an updated

comprehensive online ADMET prediction platform

enhanced with broader coverage, improved

performance, API functionality and decision support".

Nucleic Acids Research, 2024, gkae236. ISSN: 0305-

https://doi.org/10.1093/nar/gkae236

BHARATAM, P.; PODURI, R. Drug Discovery

and Development: From Targets and Molecules to

Medicines. edited by SPRINGER. Edtion ed.: Poduri,

R., Ed, 2021. ISBN 9811555338.

https://doi.org/10.1007/978-981-15-5534-3

O'BOYLE, N. M. et al. "Open Babel: An open

chemical toolbox". Journal of cheminformatics, 2011,

(1), 1-14. ISSN: 1758-2946.

https://doi.org/10.1186/1758-2946-3-33

MORRIS, G. M. et al. "AutoDock4 and

AutoDockTools4: Automated docking with selective

receptor flexibility". Journal of computational

chemistry, 2009, 30(16), 2785-2791. ISSN: 0192-

https://doi.org/10.1002/jcc.21256

PETTERSEN, E. F. et al. "UCSF Chimera-a

visualization system for exploratory research and

analysis". Journal of computational chemistry, 2004,

(13), 1605-1612. ISSN: 0192-8651.

https://doi.org/10.1002/jcc.20084

MUHAMMED, M. T.; AKI-YALCIN, E.

"Molecular docking: principles, advances, and

its applications in drug discovery". Letters in

Drug Design & Discovery, 2024, 21(3), 480-

ISSN: 1570-1808.

https://doi.org/10.2174/1570180819666220922

XU, T. et al. "Structure of the Dengue virus

helicase/nucleoside triphosphatase catalytic domain at

a resolution of 2.4 A". Journal of virology, 2005,

(16), 10278-10288. ISSN: 0022-538X.

https://doi.org/10.1128/jvi.79.16.10278-10288.2005

LUO, D. et al. "Flexibility between the protease

and helicase domains of the dengue virus NS3 protein

conferred by the linker region and its functional

implications". Journal of biological chemistry, 2010,

(24), 18817-18827. ISSN: 0021-9258.

https://doi.org/10.1074/jbc.M109.090936

DASS, K.; PRAKASH, N.; MANOGAR, P.;

MURUGESAN, R. "Current insights and future

perspectives of In silico molecular docking in dengue

virus proteins inhibition: A review". Aspects of

Molecular Medicine, 2024, 100050. ISSN: 2949-

https://doi.org/10.1016/j.amolm.2024.100050

LUCIO, F. N. M. et al. "Methylcytisine alcaloid

potentially active against dengue virus: a molecular

docking study and electronic structural

characterization". Int J Res, 2020, 8(1), 221-236.

https://doi.org/10.5281/zenodo.3633270

COUTARD, B. et al. "Assessment of Dengue

virus helicase and methyltransferase as targets for

fragment-based drug discovery". Antiviral research,

, 106, 61-70. ISSN: 0166-3542.

https://doi.org/10.1016/j.antiviral.2014.03.013

LIM, S. P. et al. "Potent allosteric dengue virus

NS5 polymerase inhibitors: mechanism of action and

resistance profiling". PLoS pathogens, 2016, 12(8),

e1005737. ISSN: 1553-7366.

https://doi.org/10.1371/journal.ppat.1005737

ELFIKY, A. A.; ISMAIL, A. M. "Molecular

docking revealed the binding of nucleotide/side

inhibitors to Zika viral polymerase solved structures".

SAR and QSAR in Environmental Research, 2018,

(5), 409-418. ISSN: 1062-936X.

https://doi.org/10.1080/1062936x.2018.1454981

MIRZA, S. B.; SALMAS, R. E.; FATMI, M. Q.;

DURDAGI, S. "Virtual screening of eighteen million

compounds against dengue virus: Combined

molecular docking and molecular dynamics

simulations study". Journal of Molecular Graphics

and Modelling, 2016, 66, 99-107. ISSN: 1093-3263.

https://doi.org/10.1016/j.jmgm.2016.03.008

ERBEL, P., SCHIERING, N., D'ARCY, A.,

RENATUS, M., et al. "Structural basis for the

activation of flaviviral NS3 proteases from dengue

and West Nile virus". Nature structural & molecular

biology, 2006, 13(4), 372-373. ISSN: 1545-9993.

https://doi.org/10.1038/nsmb1073

DE SOUSA, L. R. F. et al. "Flavonoids as

noncompetitive inhibitors of Dengue virus NS2B-NS3

protease: Inhibition kinetics and docking studies".

Bioorganic & medicinal chemistry, 2015, 23(3), 466-

ISSN: 0968-0896.

https://doi.org/10.1016/j.bmc.2014.12.015

GAUSSIAN, R.; FRISCH, M.; TRUCKS, G.;

SCHLEGEL, H. et al. Gaussian. 09, Revision A.

2016.

BECKE, A. "Density-functional thermochemistry.

III. The role of exact exchange". J. Chem. Phys, 1993,

, 5648. https://doi.org/10.1063/1.464913

ROY DENNINGTON, T. K.; MILLAM, J.

GaussView. Version 6.1.1. Semichem Inc., Shawnee

Mission, KS, 2019.

NASAR, S.; RASHID, N.; IFTIKHAR, S.

"Dengue proteins with their role in pathogenesis, and

strategies for developing an effective anti‐dengue

treatment: A review". Journal of medical virology,

, 92(8), 941-955. ISSN: 0146-6615.

https://doi.org/10.1002/jmv.25646

Publicado

2024-12-16

Como Citar

Mederos-Núñez, Y., Pérez-Garmury, Y. A., Ferrer-Serrano, A., Rojas-Vargas, J. A., & García-López, A. (2024). DISEÑO IN SILICO DE IMIDAZOLES FUNCIONALIZADOS CON AMINOÁCIDOS COMO INHIBIDORES DE LAS PROTEÍNAS NS3 Y NS5 DEL VIRUS DEL DENGUE. Revista Cubana De Química, 36(3). Recuperado de https://cubanaquimica.uo.edu.cu/index.php/cq/article/view/5385

Edição

Seção

Artículos

Artigos mais lidos pelo mesmo(s) autor(es)